EMERSON PERIN to Stem Cell Transplantation
This is a "connection" page, showing publications EMERSON PERIN has written about Stem Cell Transplantation.
Connection Strength
3.823
-
The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):169-177.
Score: 0.462
-
Till truth makes all things plain: human hearts and stem cells. Circ Res. 2014 Nov 07; 115(11):908-10.
Score: 0.406
-
Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J. 2012 Mar; 163(3):415-21, 421.e1.
Score: 0.336
-
Cell-based therapy for chronic ischemic heart disease--a clinical perspective. Cardiovasc Ther. 2011 Jun; 29(3):211-7.
Score: 0.306
-
Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):281-8.
Score: 0.273
-
Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3 Suppl 1:S110-3.
Score: 0.222
-
Stem cell therapy for cardiovascular disease. Tex Heart Inst J. 2006; 33(2):204-8.
Score: 0.220
-
The use of stem cell therapy for cardiovascular disease. Tex Heart Inst J. 2005; 32(3):390-2.
Score: 0.205
-
Stem cell therapy for cardiac diseases. Curr Opin Hematol. 2004 Nov; 11(6):399-403.
Score: 0.203
-
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003 May 13; 107(18):2294-302.
Score: 0.182
-
Adult stem cell therapy in perspective. Circulation. 2003 Feb 25; 107(7):935-8.
Score: 0.180
-
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies. ESC Heart Fail. 2021 06; 8(3):2306-2309.
Score: 0.157
-
A Path Forward for Regenerative Medicine. Circ Res. 2018 08 03; 123(4):495-505.
Score: 0.131
-
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure). Circ Res. 2018 06 08; 122(12):1703-1715.
Score: 0.129
-
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. Stem Cells Transl Med. 2016 Feb; 5(2):186-91.
Score: 0.110
-
A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials. Curr Atheroscler Rep. 2013 Aug; 15(8):341.
Score: 0.093
-
Do we have a future with transcatheter adventitial delivery of stem cells? Int J Cardiol. 2013 May 10; 165(2):217-21.
Score: 0.089
-
Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation. 2005 Jul 26; 112(4):521-6.
Score: 0.053
-
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use. Cardiovasc Res. 2022 08 24; 118(11):2428-2436.
Score: 0.044
-
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 2013 Apr 16; 127(15):1630-5.
Score: 0.023